Trial intelligence / Profile preview

NT-proBNP-guided prevention of cardiac events in type 2 diabetes without prior cardiac disease

2015-000239-34Phase 4Active

Sponsor
Medical University of Vienna
Start
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of carvedilol in cardiac morbidity (2 arms), sponsored by Medical University of Vienna. Started Nov 2015; status: active.

02

Drugs

carvedilol
03

Conditions

cardiac morbidity

Beyond the preview

Go deeper on 2015-000239-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-000239-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call